Clinical Research Facility

Haverhill, Massachusetts

Use our guide to learn which trials are right for you!

We've found
13 trials
at this facility
Diabetes Mellitus, Type 2 Clinical Trial
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Haverhill, MA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Cardiovascular Outcomes Following Treatment With Ertugliflozin in Participants With Type 2 Diabetes Mellitus and Established Vascular Disease (MK-8835-004)
Status: Enrolling, Phase III
Updated: 6/18/2015
mi
from
Haverhill, MA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Haverhill, MA
Click here to add this to my saved trials
Diabetic Nephropathy Clinical Trial
Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling, Phase III
Updated: 1/20/2016
mi
from
Haverhill, MA
Click here to add this to my saved trials
Prevention & Control Clinical Trial
Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease
Status: Enrolling, Phase III
Updated: 3/30/2016
mi
from
Haverhill, MA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Status: Enrolling, Phase III
Updated: 1/20/2016
mi
from
Haverhill, MA
Click here to add this to my saved trials
Cardiovascular Diseases Clinical Trial
A Study of Evacetrapib in High-Risk Vascular Disease
Status: Enrolling, Phase III
Updated: 1/25/2016
mi
from
Haverhill, MA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Haverhill, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/21/2016
mi
from
Haverhill, MA
Click here to add this to my saved trials
Cardiovascular Disease, Diabetes Mellitus Type 2 Clinical Trial
A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Haverhill, MA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Haverhill, MA
Click here to add this to my saved trials
Coronary Heart Disease Clinical Trial
A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Haverhill, MA
Click here to add this to my saved trials
Atherosclerosis Clinical Trial
A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of-Care Therapy for Stable Atherosclerotic Cardiovascular Disease (GLACIER)
Status: Enrolling, Phase II
Updated: 3/1/2016
mi
from
Haverhill, MA
Click here to add this to my saved trials